Worldquant Millennium Advisors LLC boosted its stake in Leidos Holdings, Inc. (NYSE:LDOS - Free Report) by 9.5% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 268,413 shares of the aerospace company's stock after buying an additional 23,183 shares during the period. Worldquant Millennium Advisors LLC owned 0.20% of Leidos worth $43,751,000 at the end of the most recent reporting period.
Several other large investors have also bought and sold shares of the company. Ballentine Partners LLC boosted its stake in Leidos by 3.5% during the third quarter. Ballentine Partners LLC now owns 1,822 shares of the aerospace company's stock worth $297,000 after acquiring an additional 62 shares in the last quarter. Key Financial Inc boosted its position in shares of Leidos by 6.5% in the 2nd quarter. Key Financial Inc now owns 1,141 shares of the aerospace company's stock worth $166,000 after purchasing an additional 70 shares in the last quarter. Asahi Life Asset Management CO. LTD. grew its stake in shares of Leidos by 3.2% in the 3rd quarter. Asahi Life Asset Management CO. LTD. now owns 2,280 shares of the aerospace company's stock worth $372,000 after buying an additional 70 shares during the last quarter. Somerset Trust Co increased its position in Leidos by 3.5% during the 3rd quarter. Somerset Trust Co now owns 2,429 shares of the aerospace company's stock valued at $396,000 after buying an additional 83 shares in the last quarter. Finally, Apella Capital LLC raised its stake in Leidos by 0.8% during the third quarter. Apella Capital LLC now owns 11,366 shares of the aerospace company's stock valued at $1,878,000 after buying an additional 89 shares during the last quarter. 76.12% of the stock is owned by institutional investors.
Leidos Stock Performance
Shares of NYSE LDOS traded down $0.61 during midday trading on Friday, hitting $163.15. 976,697 shares of the company's stock traded hands, compared to its average volume of 1,726,176. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.15 and a current ratio of 1.23. The stock has a market capitalization of $21.77 billion, a price-to-earnings ratio of 18.58, a price-to-earnings-growth ratio of 1.11 and a beta of 0.64. The firm has a fifty day moving average of $171.81 and a 200 day moving average of $157.36. Leidos Holdings, Inc. has a 1 year low of $105.52 and a 1 year high of $202.90.
Leidos (NYSE:LDOS - Get Free Report) last issued its quarterly earnings data on Tuesday, October 29th. The aerospace company reported $2.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.96 by $0.97. The company had revenue of $4.19 billion for the quarter, compared to analyst estimates of $4.06 billion. Leidos had a net margin of 7.37% and a return on equity of 30.31%. Leidos's revenue was up 6.9% compared to the same quarter last year. During the same period last year, the company posted $2.03 earnings per share. On average, analysts forecast that Leidos Holdings, Inc. will post 10.04 earnings per share for the current year.
Leidos Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 31st. Investors of record on Monday, December 16th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.98%. The ex-dividend date is Monday, December 16th. This is a positive change from Leidos's previous quarterly dividend of $0.38. Leidos's payout ratio is 18.22%.
Insider Activity at Leidos
In other Leidos news, Director Noel B. Geer purchased 2,000 shares of the company's stock in a transaction dated Wednesday, November 20th. The shares were acquired at an average price of $161.13 per share, for a total transaction of $322,260.00. Following the completion of the purchase, the director now owns 2,000 shares of the company's stock, valued at approximately $322,260. The trade was a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Surya N. Mohapatra sold 2,748 shares of the stock in a transaction that occurred on Thursday, November 7th. The shares were sold at an average price of $194.97, for a total transaction of $535,777.56. Following the completion of the transaction, the director now directly owns 20,001 shares of the company's stock, valued at $3,899,594.97. The trade was a 12.08 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.96% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
A number of equities research analysts have recently commented on LDOS shares. Royal Bank of Canada increased their target price on Leidos from $145.00 to $180.00 and gave the stock a "sector perform" rating in a research note on Wednesday, October 30th. Wells Fargo & Company reduced their price objective on shares of Leidos from $230.00 to $205.00 and set an "overweight" rating for the company in a research note on Tuesday, November 26th. TD Cowen lifted their target price on shares of Leidos from $175.00 to $200.00 and gave the stock a "buy" rating in a report on Wednesday, October 30th. Truist Financial cut their price target on shares of Leidos from $205.00 to $185.00 and set a "buy" rating on the stock in a report on Friday, November 22nd. Finally, Barclays boosted their price objective on shares of Leidos from $165.00 to $210.00 and gave the stock an "overweight" rating in a report on Monday, November 4th. Three equities research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $187.36.
View Our Latest Research Report on LDOS
Leidos Company Profile
(
Free Report)
Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.
Featured Stories
Before you consider Leidos, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Leidos wasn't on the list.
While Leidos currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.